Breast Cancer News and Research

Latest Breast Cancer News and Research

High fiber diet may help prevent breast cancer: Study

A new study shows women who eat more fiber are less likely to get breast cancer. Chinese researchers found those who ate the most of the healthy plant components were 11 percent less likely to develop breast cancer than women who ate the least.

29 Jul 2011

Celgene reports second quarter total revenue of $1.18 billion

Celgene Corporation announced non-GAAP net income of $417 million, or non-GAAP diluted earnings per share of $0.89, for the quarter ended June 30, 2011. Non-GAAP net income for the second quarter of 2010 was $323 million, or non-GAAP diluted earnings per share of $0.69.

28 Jul 2011

Scientists show how RET gene in breast cancer cells responds to estrogen

Using human breast cancer cells and the protein that causes fireflies to glow, a Johns Hopkins team has shed light on why some breast cancer cells become resistant to the anticancer effects of the drug tamoxifen. The key is a discovery of two genetic "dimmer switches" that apparently control how a breast cancer gene responds to the female hormone estrogen.

28 Jul 2011

Dense breasts raise risk of breast cancer

A new study supported by the National Cancer Institute found a higher cancer risk for women with dense breasts. It's the tissue in women's breast that can differ by heredity, from more fatty to more dense tissue. Fatty tissue shows up dark on a mammogram, but fibrous or dense tissue shows up white. So do small tumors, which can make them hard to find. The study was published in the July 27 online edition of the Journal of the National Cancer Institute.

27 Jul 2011

Breast cancer survival and lymph nodes

A large new study has found that a lymph node-sparing test hailed as revolutionary for its conservative approach does not lead to longer survival times for women undergoing lumpectomies whose early-stage breast cancer has spread microscopically.

27 Jul 2011

Women with early-stage breast cancer do not benefit from lymph node removal

A new study shows that removing lymph nodes due to the presence of occult, or microscopic, cancer cells found in the sentinel lymph node - the one closest to the tumor -- has no impact on survival outcomes of women with early-stage breast cancer.

27 Jul 2011

Lipofilling found safe after breast cancer surgery

Preliminary experience suggests that lipofilling—using fat from elsewhere in the patient's body for contouring of the breasts—is a safe procedure for women who have undergone breast cancer surgery, reports a study in the August issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).

27 Jul 2011

High-dose vitamin D reduces musculoskeletal pain in breast cancer patients

High-dose vitamin D relieves joint and muscle pain for many breast cancer patients taking estrogen-lowering drugs, according to a new study from Washington University School of Medicine in St. Louis.

27 Jul 2011

Lack of genetic screening for cancers

In a new study published Monday in the journal Cancer, it was noted that while genetic testing to check if a woman has the BRCA1 or BRCA2 mutations can be a useful tool for preventing breast cancer and ovarian cancer in some cases, many doctors are not referring patients.

26 Jul 2011

Racal differences in breast cancer survival: Study

Black women are more likely to die from breast cancer than white women with obesity considered a significant factor. But a new study shows that that the cause of the difference does not lie in obesity alone. As a group, black women in the U.S. tend to be heavier than whites and researchers had thought that might explain why only 78 percent survive five years after diagnosis, compared to 90 percent of white women.

26 Jul 2011

Bionovo completes 13 weeks repeat dose animal toxicology studies for Menerba

Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, announced today the successful completion of 13 weeks repeat dose animal toxicology studies with Menerba.

25 Jul 2011

Ranbaxy announces launch of Letrozole Tablets in UK, Romania and France

Ranbaxy Laboratories Limited today announced the launch of Letrozole Tablets 2.5 mg in UK, Romania and France, on Day-1. Letrozole is the bio equivalent of Femara, the innovator product of Novartis, that has a market size of USD 58 Mn in UK, USD 95 Mn in France and USD 5.5 Mn in Romania.

25 Jul 2011

Better targeting of pharmaceuticals to patient's genetic profile could save around $110B annually

Genetic testing made possible by the mapping of the human genome can help the US cut costs and create jobs while at the same time improving survival rates for such diseases as cancer, HIV, and heart disease.

25 Jul 2011

Two genetic variations can identify children at higher risk of radiation-induced second cancers

A genome-wide association study published in the August issue of Nature Medicine has found two tiny genetic variations that can predict which patients with Hodgkin's lymphoma are most likely to develop radiation-induced second cancers years after treatment.

25 Jul 2011

New method for detecting breast cancer at 'stage 0'

RNL Natural Co., Ltd, a leading biotech company specialized in adult stem cell therapeutics affiliated with RNL BIO Co., Ltd., introduced on June 22, 2011 a new method of detecting breast cancer as early as at 'stage 0' through breath VOCs.

25 Jul 2011

Sigma Life Science releases breast cancer-specific knockout and knockin cell lines for drug research

Sigma Life Science, the innovative biological products and services research business of Sigma-Aldrich, today announced the expansion of its CompoZr® Oncology Disease Model portfolio with the release of the first in its collection of breast cancer-specific knockout and knockin cell lines for drug discovery and research.

22 Jul 2011

SG Austria acquisition benefits Nuvilex with $1.5M in grant funding

Nuvilex, Inc. announced today that as part of its acquisition of SG Austria, Nuvilex will benefit from grant funding previously awarded to SG Austria for its live-cell encapsulation activities and other projects. The total grant funding awarded to SG Austria is approximately $1.5 million.

22 Jul 2011

The next round of mammogram advice

The American College of Obstetricians and Gynecologists issued new recommendations that women should begin getting annual mammograms at age 40.

22 Jul 2011

Leading cancer specialists and researchers establish Australia’s first comprehensive ‘Cancer Survivors Centre’

Australia’s first comprehensive treatment and research centre for the growing number of cancer survivors will be announced at the annual Ride for Life luncheon at NSW Parliament House today.

22 Jul 2011

Taller women more prone to cancer: Study

New research has shown that taller women could be more prone to suffering from cancer. The British study published online in the medical journal The Lancet on Thursday said cancer risk rose about 16% for every 4-inch rise in height. Increasing height heightened the chances of cancers of breast, ovary, womb, bowel, leukemia and malignant melanoma (skin cancer) the study found.

21 Jul 2011